Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Other financing activities (2024)

Historic Other financing activities for Kairos Pharma (KAPA) over the last 1 years, with Q3 2024 value amounting to $348000.0.

  • Kairos Pharma's Other financing activities changed N/A to $348000.0 in Q3 2024 from the same period last year, while for Dec 2024 it was $390000.0, marking a year-over-year change of. This contributed to the annual value of $390000.0 for FY2024, which is 823.53% down from last year.
  • Latest data reveals that Kairos Pharma reported Other financing activities of $348000.0 as of Q3 2024.
  • In the past 5 years, Kairos Pharma's Other financing activities ranged from a high of $348000.0 in Q3 2024 and a low of -$47000.0 during Q2 2024